Human Genome Epidemiology Literature Finder
Records 1 - 21 (of 21 Records) |
Query Trace: Breast Neoplasms and APOBEC3B[original query] |
---|
APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis 2013 Oct 34 (10): 2240-3. Xuan Dennis, Li Guoliang, Cai Qiuyin, Deming-Halverson Sandra, Shrubsole Martha J, Shu Xiao-Ou, Kelley Mark C, Zheng Wei, Long Jiro |
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer. Nature genetics 2014 May 46 (5): 487-91. Nik-Zainal Serena, Wedge David C, Alexandrov Ludmil B, Petljak Mia, Butler Adam P, Bolli Niccolo, Davies Helen R, Knappskog Stian, Martin Sancha, Papaemmanuil Elli, Ramakrishna Manasa, Shlien Adam, Simonic Ingrid, Xue Yali, Tyler-Smith Chris, Campbell Peter J, Stratton Michael |
Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population. Journal of cancer research and clinical oncology 2015 Aug . Göhler Stella, Da Silva Filho Miguel Inacio, Johansson Robert, Enquist-Olsson Kerstin, Henriksson Roger, Hemminki Kari, Lenner Per, Försti As |
APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers. Breast cancer (Tokyo, Japan) 2015 Oct . Tsuboi Miki, Yamane Arito, Horiguchi Jun, Yokobori Takehiko, Kawabata-Iwakawa Reika, Yoshiyama Shinji, Rokudai Susumu, Odawara Hiroki, Tokiniwa Hideaki, Oyama Tetsunari, Takeyoshi Izumi, Nishiyama Masahi |
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer. PloS one 2016 11 (8): e0161731. Liu Jingjing, Sieuwerts Anieta M, Look Maxime P, van der Vlugt-Daane Michelle, Meijer-van Gelder Marion E, Foekens John A, Hollestelle Antoinette, Martens John W |
Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation. Breast cancer research : BCR 2016 18 (1): 56. Wen Wei Xiong, Soo Jaslyn Sian-Siu, Kwan Pui Yoke, Hong Elaine, Khang Tsung Fei, Mariapun Shivaani, Lee Christine Shu-Mei, Hasan Siti Norhidayu, Rajadurai Pathmanathan, Yip Cheng Har, Mohd Taib Nur Aishah, Teo Soo Hwa |
Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population. BMC cancer 2016 16 (1): 165. Marouf Chaymaa, Göhler Stella, Filho Miguel Inacio Da Silva, Hajji Omar, Hemminki Kari, Nadifi Sellama, Försti As |
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women. PloS one 2016 11 (12): e0168090. Tokunaga Eriko, Yamashita Nami, Tanaka Kimihiro, Inoue Yuka, Akiyoshi Sayuri, Saeki Hiroshi, Oki Eiji, Kitao Hiroyuki, Maehara Yoshihi |
Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. Nature genetics 2016 Sep . Middlebrooks Candace D, Banday A Rouf, Matsuda Konichi, Udquim Krizia-Ivana, Onabajo Olusegun O, Paquin Ashley, Figueroa Jonine D, Zhu Bin, Koutros Stella, Kubo Michiaki, Shuin Taro, Freedman Neal D, Kogevinas Manolis, Malats Nuria, Chanock Stephen J, Garcia-Closas Montserrat, Silverman Debra T, Rothman Nathaniel, Prokunina-Olsson Ludmi |
Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 May . Revathidevi Sundaramoorthy, Manikandan Mayakannan, Rao Arunagiri Kuha Deva Magendhra, Vinothkumar Vilvanathan, Arunkumar Ganesan, Rajkumar Kottayasamy Seenivasagam, Ramani Rajendran, Rajaraman Ramamurthy, Ajay Chandrasekar, Munirajan Arasambattu Kann |
Germline copy number variations are associated with breast cancer risk and prognosis. Scientific reports 2017 11 7 (1): 14621. Kumaran Mahalakshmi, Cass Carol E, Graham Kathryn, Mackey John R, Hubaux Roland, Lam Wan, Yasui Yutaka, Damaraju Sambasivar |
Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer. Breast cancer research and treatment 2017 Jan . Radmanesh Hoda, Spethmann Tessa, Enßen Julia, Schürmann Peter, Bhuju Sabin, Geffers Robert, Antonenkova Natalia, Khusnutdinova Elza, Sadr-Nabavi Ariane, Shandiz Fatemeh Homaei, Park-Simon Tjoung-Won, Hillemanns Peter, Christiansen Hans, Bogdanova Natalia, Dörk Thi |
APOBEC3B Gene Expression in Ductal Carcinoma In Situ and Synchronous Invasive Breast Cancer. Cancers 2019 Jul 11 (8): . Sieuwerts Anieta M, Doebar Shusma C, de Weerd Vanja, Verhoef Esther I, Beauford Corine M, Agahozo Marie C, Martens John W M, van Deurzen Carolien H |
Immune gene expression profiling reveals heterogeneity in luminal breast tumors. Breast cancer research : BCR 2019 12 21 (1): 147. Zhu Bin, Tse Lap Ah, Wang Difei, Koka Hela, Zhang Tongwu, Abubakar Mustapha, Lee Priscilla, Wang Feng, Wu Cherry, Tsang Koon Ho, Chan Wing-Cheong, Law Sze Hong, Li Mengjie, Li Wentao, Wu Suyang, Liu Zhiguang, Huang Bixia, Zhang Han, Tang Eric, Kan Zhengyan, Lee Soohyeon, Park Yeon Hee, Nam Seok Jin, Wang Mingyi, Sun Xuezheng, Jones Kristine, Zhu Bin, Hutchinson Amy, Hicks Belynda, Prokunina-Olsson Ludmila, Shi Jianxin, Garcia-Closas Montserrat, Chanock Stephen, Yang Xiaohong |
Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer. Breast cancer research and treatment 2020 7 183 (3): 697-704. Kim Se Hyun, Ahn Soomin, Suh Koung Jin, Kim Yu Jung, Park So Yeon, Kang Eunyoung, Kim Eun-Kyu, Kim In Ah, Chae Sumin, Choi Murim, Kim Jee Hy |
Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort. Journal of cancer research and clinical oncology 2020 Apr . Vitiello Glauco Akelinghton Freire, de Sousa Pereira Nathalia, Amarante Marla Karine, Banin-Hirata Bruna Karina, Campos Clodoaldo Zago, de Oliveira Karen Brajão, Losi-Guembarovski Roberta, Watanabe Maria Angelica Eha |
APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status. Carcinogenesis 2020 1 41 (8): 1030-1037. Udquim Krizia-Ivana, Zettelmeyer Clara, Banday A Rouf, Lin Seraph Han-Yin, Prokunina-Olsson Ludmi |
Different members of the APOBEC3 family of DNA mutators have opposing associations with the landscape of breast cancer. American journal of cancer research 2021 11 11 (10): 5111-5125. Asaoka Mariko, Patnaik Santosh K, Ishikawa Takashi, Takabe Kazua |
Germline APOBEC3B deletion increases somatic hypermutation in Asian breast cancer that is associated with Her2 subtype, PIK3CA mutations, and immune activation. International journal of cancer 2021 1 . Pan Jia-Wern, Zabidi Muhammad Mamduh Ahmad, Chong Boon-Keat, Meng Mei-Yee, Ng Pei-Sze, Hasan Siti Norhidayu, Sandey Bethan, Bahnu Saira, Rajadurai Pathmanathan, Yip Cheng-Har, Rueda Oscar M, Caldas Carlos, Chin Suet-Feung, Teo Soo-Hwa |
APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival. American journal of cancer research 2022 3 12 (2): 744-762. Wu Rongrong, Oshi Masanori, Asaoka Mariko, Huyser Michelle R, Tokumaru Yoshihisa, Yamada Akimitsu, Yan Li, Endo Itaru, Ishikawa Takashi, Takabe Kazua |
The APOBEC3B c.783delG Truncating Mutation Is Not Associated with an Increased Risk of Breast Cancer in the Polish Population. Genes 2023 7 14 (7): . Katarzyna Gliniewicz, Wojciech Klu?niak, Dominika Woko?orczyk, Tomasz Huzarski, Klaudia Stempa, Helena Rudnicka, Anna Jakubowska, Marek Szwiec, Joanna Jarkiewicz-Tretyn, Mariusz Naczk, Tomasz Kluz, Tadeusz D?bniak, Jacek Gronwald, Jan Lubi?ski, Steven A Narod, Mohammad R Akbari, Cezary Cybuls |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: